At the end of January, we launched a new feature on our website that shows how NINDS and the research we support contribute to the discovery and development of treatments for neurological disorders.
NINDS Director Walter J. Koroshetz and NCI Director Norman E. Sharpless
NIH relies heavily on investigator-initiated R01 grants to fuel its science. This democratic approach is responsible in large part for the success of the American biomedical research enterprise.
As the Nation’s medical research agency, one of NIH’s most important roles is leveraging our resources to respond to emerging public health crises.
The toll that neurological disorders exact on patients and their families is truly tragic. Yet, looking forward there is cause for real optimism for some conditions.
The beginning of a new year has a way of sneaking up on all of us, but we always gain helpful perspectives by stopping to reflect on the year that has passed.
By: Nina Schor, NINDS Deputy Director
I’m a news junkie, and I love stories, especially those about science. You may not realize it, but every day as part of the NINDS research community, you are generating incredible news.
This week, more than thirty thousand neuroscientists are coming to Washington, DC for the annual meeting of the Society for Neuroscience (SfN).